Patients with atrial fibrillation have significantly lower cardiac PI3K-AKT activity, and the use of BTK attenuates the Akt response and thus predisposes to cardiac fibrosis and atrial arrhythmias, such as atrial fibrillation [13]. The gene discussed is AKT1; the disease is atrial fibrillation.